- Report
- April 2021
- 35 Pages
Global
From €3123EUR$3,250USD£2,681GBP
- Report
- December 2020
- 60 Pages
Global
From €3123EUR$3,250USD£2,681GBP
- Report
- December 2020
- 60 Pages
Global
From €2642EUR$2,750USD£2,268GBP
- Report
- December 2020
- 60 Pages
Global
From €3123EUR$3,250USD£2,681GBP
- Report
- January 2022
- 112 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- May 2023
- 450 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- February 2022
- 228 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- September 2022
- 283 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Report
- August 2022
- 118 Pages
Global
From €4324EUR$4,500USD£3,712GBP
- Report
- January 2023
- 116 Pages
Global
From €4324EUR$4,500USD£3,712GBP
- Report
- January 2023
- 151 Pages
North America
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- January 2023
- 161 Pages
Middle East, Africa
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- January 2023
- 166 Pages
Europe
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- January 2023
- 168 Pages
Asia Pacific
From €2018EUR$2,100USD£1,732GBP
€2883EUR$3,000USD£2,474GBP
- Report
- November 2022
- 220 Pages
Global
From €3060EUR$3,185USD£2,627GBP
€4372EUR$4,550USD£3,753GBP
- Report
- November 2022
- 107 Pages
Global
From €3795EUR$3,950USD£3,258GBP
- Report
- September 2020
- 148 Pages
Global
From €10564EUR$10,995USD£9,069GBP
- Report
- January 2020
- 130 Pages
Global
From €10564EUR$10,995USD£9,069GBP
- Report
- October 2019
- 128 Pages
Global
From €10564EUR$10,995USD£9,069GBP
- Report
- June 2019
- 53 Pages
Global
From €6721EUR$6,995USD£5,770GBP
Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more
